• 0 Posts
  • 1.53K Comments
Joined 2 years ago
cake
Cake day: January 2nd, 2025

help-circle
  • Onomatopoeia@lemmy.cafetoSelfhosted@lemmy.world•DC UPS for router?
    link
    fedilink
    English
    arrow-up
    2
    arrow-down
    3
    ·
    17 hours ago

    Yea, small business routers (think old Cisco boxes) use a 5A laptop-style power supply. I suspect this is what OP’s using, as I’ve never seen a consumer model with such power specs. Consumer stuff is built around the cheapest hardware they can get away with.

    Thing is, I don’t doubt the Cisco box (or similar business units) may need that much juice at times. Put your hand over one that’s not connected but powered on and they get hot.

    Stuff like that they really don’t care about power consumption during design, just capability.




  • I’m with you.

    But it’s a tough call on Graphene’s part too - right now only us in-the-know have any awareness of the implications of Graphene’s approach (security first) or even alternative OS for Android devices.

    They probably think getting that out to the greater public is the crucial first step - get that accepted as a thing.

    Also, by the time the general public is using Graphene devices, other phones may be shipping with the necessary hardware. Remember, most people are buying new phones every couple years when their old one starts misbehaving - to most people a phone is a toaster.













  • Yes, because it’s ambiguous.

    Define sugar.

    Define consume.

    It’s a blanket statement without nuance.

    Also everyone consumes sugars in some form - i.e. Carbohydrates.

    The simpler the carb, the greater the volume, the more of a concern/risk.

    Such ambiguous statements are a major problem with the medical community these days, as all sorts of things get communicated without any quantification.

    Things like you’re at a greater risk of X because of Y.

    OK, how much greater? 60%? Or 0.006%? Is that absolute risk or relative risk?

    The blood pressure debate is awash with this problem. As is the realm of biologics (used for autoimmune/autoinflammatory diseases) when looking at increased risk for infections. Yes, there’s an increased risk, but across the board of all biologics that increase is something like 1 case in 5000 man-years - with no determination if that’s truly because of the biologic or because they study participants already have immune dysregulation

    And for specific biologics and specific diseases, there’s no demonstrable increase in risk, based on massive meta-analysis.

    The devil is in the details.